drugset / Trial / NCT00303004
Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to investigate if combination treatment with Bosentan and Sildenafil to patients with Eisenmenger syndrome is beneficial.
Timeline
- Start
- 2006-03
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bosentan | Other / unclassified | — | — |
| Subject | Sildenafil | Unknown | 50 mg | — |